CAP paid for a write-up on Stock-head today - 'Clarity to drive development of Carpentaria’s Hawsons iron project'A bit of advertising never hurts - on yer Peter!.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
